Polymorphism in Pharmaceutical Compounds
A special issue of Crystals (ISSN 2073-4352). This special issue belongs to the section "Crystalline Materials".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 3618
Special Issue Editor
Special Issue Information
Dear Colleagues,
Polymorphism is the ability of solids to be able to exist in two or more crystalline forms with different arrangements in the crystal lattice. Polymorphic forms of a drug differ in the physicochemical properties such as dissolution and solubility, chemical and physical stability, flowability and hygroscopicity and, hence, differ in various important drug outcomes, such as drug efficacy, bioavailability, and even toxicity. Polymorphic studies are important as a particular polymorph can be responsible for a particular property which might not be exhibited by any other form. In this Special Issue, we would like to invite the authors who can write their results, or review in the direction research scope such as polymorphism, applications in pharmaceuticals drugs and challenges, manufacturing of drugs. Hence we like to have researchers contribution in this scope.
Dr. Geetha Bolla
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Crystals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Polymorphs
- pharma drugs
- crystallization
- physicochemical property
